A Clinical Trial With KJ103 in Anti-GBM Disease

Clinical trial NCT06607016 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06607016
Sponsor: Shanghai Bao Pharmaceuticals Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anti-Glomerular Basement Membrane Disease

Start date: 2024-10-21
Primary completion: 2025-12-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.